Atricure Inc. Stock
Price
Target price
€32.00
€32.00
4.100%
1.26
4.100%
€42.94
22.09.25 / Frankfurt
WKN: A0ES9W / Symbol: ATRC / Name: AtriCure / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Atricure Inc. Stock
A very strong showing by Atricure Inc. today, with an increase of €1.26 (4.100%) compared to yesterday's price.
Atricure Inc. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
With a target price of 42 € there is a positive potential of 31.25% for Atricure Inc. compared to the current price of 32.0 €.
Pros and Cons of Atricure Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atricure Inc. | 4.100% | -50.419% | -50.419% | -50.419% | -50.419% | -50.419% | -5.706% |
| SI-BONE Inc | -0.800% | 0.000% | -7.914% | -7.914% | -1.538% | - | - |
| Orasure Tech | 2.880% | -0.714% | 13.008% | -27.979% | -18.713% | -27.225% | -74.259% |
| scPharmaceuticals | 0.380% | -0.171% | 20.982% | 0.472% | 44.506% | 3.128% | -23.246% |
Comments
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $51.00 to $44.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
News
AtriCure (ATRC) Q2 Revenue Jumps 17%
AtriCure (NASDAQ:ATRC), a medical device company specializing in cardiac surgical technologies, delivered its earnings release on July 29, 2025, reporting results that outpaced Wall Street consensus
